Stay updated on Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.1%
    Check dated 2025-05-08T13:32:08.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:56:12.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T22:35:23.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a phase 2 trial for advanced sarcomas and the addition of new collaborators and a revision number. Notably, the name of the study chair, Antoine Italiano, has been retained.
    Difference
    35%
    Check dated 2025-04-16T14:51:31.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T10:22:47.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.3%
    Check dated 2025-04-01T23:40:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.